The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

Diabetes

Volumn 51, Issue 3, 2002, Pages 797-802

  Mayerson, Adam B ^a   Hundal, Ripudaman S ^a   Dufour, Sylvie ^a   Lebon, Vincent ^a   Befroy, Douglas ^a   Cline, Gary W ^a   Enocksson, Staffan ^a   Inzucchi, Silvio E ^a   Shulman, Gerald I ^a   Petersen, Kitt F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; ROSIGLITAZONE; TRIACYLGLYCEROL;

ADIPOCYTE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN SENSITIVITY; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SKELETAL MUSCLE;

EID: 0036310037     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.3.797     Document Type: Article

References (48)

1. Thiazolidinediones: A new class of antidiabetic drugs
2. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma
3. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial
4. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
5. Mechanism of troglitazone action in type 2 diabetes
6. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
7. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
8. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance
9. The hormone resistin links obesity to diabetes
10. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes
11. Mechanism of free fatty acid-induced insulin resistance in humans
12. Effects of free fatty acids on glucose transport and IRS-l-associated phosphatidylinositol 3-kinase activity
13. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade
14. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans
15. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice
16. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
17. 1H NMR spectroscopy study
18. Skeletal muscle triglyceride levels are inversely related to insulin action
19. Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: A 13C nuclear magnetic resonance study
20. Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat
21. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients
22. Animal calorimetry: Analysis of the oxidation of mixtures of carbohydrates and fat. A correction
23. Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissue
24. Microdialysis in the study of extracellular levels of amino acids in the rat brain
25. Assessment of adipose tissue metabolism in man: Comparison of Fick and microdialysis techniques
26. Ethanol may be used with the microdialysis technique to monitor blood flow changes in skeletal muscle: Dialysate glucose concentrations is bloodflow dependent
27. Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans
28. Improvements on an in vivo automatic shimming method [FASTERMAP]
29. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: Two lipid compartments in muscle tissue
30. Densitometric analysis of body composition: Revision of some quantitative assumptions
31. A microfluorometric method for the determination of free fatty acids in plasma
32. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats
33. Cellular mechanisms of insulin resistance
34. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
35. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: Comparison with PPAR-gamma activation
36. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes
37. Effect of troglitazone on body fat distribution in type 2 diabetic patients
38. Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes
39. Efficacy of troglitazone on body fat distribution in type 2 diabetes
40. Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy: A randomized controlled trial
41. Relationship between visceral fat and enhanced peripheral hepatic insulin sensitivity after pioglitazone in type 2 diabetes
42. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes
43. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation
44. Effect of troglitazone on leptin production: Studies in vitro and in human subjects
45. Increased feeding in fatty Zucker rats by the thiazolidinedione BRL 49653 (rosiglitazone) and the possible involvement of leptin and hypothalamic neuropeptide Y
46. Troglitazone reduces leptin concentration but increases hunger in NIDDM patients
47. Leptin concentrations in the polycystic ovary syndrome